CONCLUSION

This integrative review synthesizes current evidence on the mechanistic roles of probiotics in modulating the gut–immune axis and their potential as sustainable alternatives to AGPs in poultry production. Key findings demonstrate that selected probiotic strains, particularly Lactobacillus spp., Bacillus spp., and Bifidobacterium spp., enhance innate immunity through macrophage activation and cytokine regulation, strengthen adaptive responses via increased mucosal IgA and systemic IgY production, improve lymphoid organ development, and reduce pathogen colonization through competitive exclusion and antimicrobial metabolite production. These immunomodulatory effects are associated with improved intestinal barrier integrity, balanced inflammatory responses, enhanced vaccine responsiveness, and better performance metrics under both controlled and field conditions. Postbiotics and paraprobiotics further expand options by offering greater stability and safety profiles while retaining bioactive benefits.

Probiotics provide a viable, natural strategy for supporting poultry health and productivity in the post-AGP era. Strategic implementation, through early-life or continuous supplementation, synbiotic combinations, and integration with vaccination programs, can reduce reliance on therapeutic antibiotics, lower pathogen loads (Salmonella, Campylobacter), improve feed efficiency, and enhance flock resilience to stress and disease. Commercial adoption should prioritize strain-specific selection, optimal dosing, stable delivery forms, and on-farm monitoring to maximize economic returns and ensure consistent outcomes across production systems.

This review offers a comprehensive, mechanism-driven synthesis that positions immune modulation as the central framework rather than a secondary outcome. It integrates molecular, cellular, organ-level, and production data, clearly distinguishes strain-specific effects, and bridges controlled research with practical industry applications, providing actionable guidance for veterinarians, nutritionists, and producers.

Considerable heterogeneity exists across studies due to differences in strains, dosages, experimental designs, bird types, and environmental conditions. Many mechanistic insights rely on in_ vitro_ or mammalian-derived data, with fewer direct avian molecular validations. Field reproducibility can be lower than in controlled trials, and long-term ecological impacts, cost–benefit analyses, and regulatory harmonization require further clarification.

Priority research directions include large-scale, multi-site field trials with standardized immune biomarkers, precision dosing guided by multi-omics and AI/ML approaches, development of recombinant and heat-stable formulations, and longitudinal evaluations of sustainability outcomes (AMR reduction, environmental impact). Breed-specific and locally adapted strains, early-life/_in _ovo interventions, and comparative studies of live probiotics versus postbiotics/paraprobiotics will further strengthen translational reliability and support climate-resilient poultry production.

In conclusion, probiotics represent a scientifically sound and practically viable tool for enhancing immune competence, disease resistance, and sustainable productivity in modern poultry systems. By shifting from generalized supplementation to precision, mechanism-based strategies, the industry can achieve meaningful reductions in antibiotic use while maintaining or improving flock health and performance. Continued research and evidence-based implementation will be essential to fully realize the potential of probiotics within a One Health framework for responsible and resilient poultry production.